These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17692573)

  • 21. The use of levetiracetam in a child with nonconvulsive status epilepticus.
    Alehan F; Ozcay F; Haberal M
    J Child Neurol; 2008 Mar; 23(3):331-3. PubMed ID: 18192652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seizures in Pediatric Patients With Liver Transplant and Efficacy of Levetiracetam.
    Kılıç B; Güngör S; Arslan M; Selimoğlu MA; Yılmaz S
    J Child Neurol; 2017 Jul; 32(8):740-745. PubMed ID: 28420301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral effects of levetiracetam mitigated by pyridoxine.
    Davis GP; McCarthy JT; Magill DB; Coffey B
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):209-11. PubMed ID: 19364300
    [No Abstract]   [Full Text] [Related]  

  • 24. Levetiracetam in children with refractory status epilepticus.
    Gallentine WB; Hunnicutt AS; Husain AM
    Epilepsy Behav; 2009 Jan; 14(1):215-8. PubMed ID: 18926926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy.
    Vles GF; Hendriksen JG; Visschers A; Speth L; Nicolai J; Vles JS
    Dev Med Child Neurol; 2009 Jun; 51(6):487-90. PubMed ID: 19018837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of levetiracetam in neonates with seizures.
    Merhar SL; Schibler KR; Sherwin CM; Meinzen-Derr J; Shi J; Balmakund T; Vinks AA
    J Pediatr; 2011 Jul; 159(1):152-154.e3. PubMed ID: 21592494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiepileptic drugs in aneurysmal subarachnoid hemorrhage.
    Zubkov AY; Wijdicks EF
    Rev Neurol Dis; 2008; 5(4):178-81. PubMed ID: 19122570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G; Gomceli YB; Unal Y; Inan LE
    Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
    Sethi NK; Milligan TA; Hurwitz S; Bromfield EB
    Neurology; 2009 Jul; 73(2):159; author reply 159. PubMed ID: 19597140
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Drug-induced psychosis with levetiracetam.
    Mula M; Trimble MR
    Can J Psychiatry; 2005 Dec; 50(14):948; author reply 948. PubMed ID: 16494265
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P; Li Kan ; Maytal J
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid dosage titration of levetiracetam in children.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin rash following levetiracetam.
    Bhoi SK; Kalita J; Misra UK
    Seizure; 2016 Apr; 37():45-7. PubMed ID: 26987035
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous levetiracetam in children with epilepsy.
    Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case series.
    Bilo L; Meo R; de Leva MF; De Simone R; Di Nocera P; Pisani F; Striano S
    Clin Neuropharmacol; 2008; 31(4):221-5. PubMed ID: 18670245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study.
    Belcastro V; Costa C; Galletti F; Autuori A; Pierguidi L; Pisani F; Calabresi P; Parnetti L
    Epilepsy Res; 2008 Dec; 82(2-3):223-6. PubMed ID: 18829259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-convulsive epileptic status reverted with intravenous levetiracetam].
    Callén-Soto A; Pérez-Pérez S; Robles-Del Olmo B
    Rev Neurol; 2008 Nov 1-15; 47(9):501-2. PubMed ID: 18985603
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Levetiracetam and restless leg syndrome].
    Lasaosa SS; Pellicer PL; Fernández LG
    Neurologia; 2008; 23(6):395-6. PubMed ID: 18597196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.